The impact of uterine leiomyomas: a national survey of affected women.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 23891629.
- Also identified by DOI 10.1016/j.ajog.2013.07.017 and PMC identifier 4167669.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We sought to characterize the impact of uterine leiomyomas (fibroids) in a racially diverse sample of women in the United States. A total of 968 women (573 white, 268 African American, 127 other races) aged 29-59 years with self-reported symptomatic uterine leiomyomas participated in a national survey. We assessed diagnosis, information seeking, attitudes about fertility, impact on work, and treatment preferences. Frequencies and percentages were summarized. The χ(2) test was used to compare age groups. Women waited an average of 3.6 years before seeking treatment for leiomyomas, and 41% saw ≥2 health care providers for diagnosis. Almost a third of employed respondents (28%) reported missing work due to leiomyoma symptoms, and 24% believed that their symptoms prevented them from reaching their career potential. Women expressed desire for treatments that do not involve invasive surgery (79%), preserve the uterus (51%), and preserve fertility (43% of women aged <40 years). Uterine leiomyomas cause significant morbidity. When considering treatment, women are most concerned about surgical options, especially women aged <40 years who want to preserve fertility.
Medical subject headings
- Cost of Illness
- Fertility
- Leiomyoma
- Uterine Neoplasms